Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.68 +0.02 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$1.67 -0.01 (-0.54%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMTI vs. ARAY, RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, IDXX, and EW

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Accuray (ARAY), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), and Edwards Lifesciences (EW). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs. Its Competitors

Rockwell Medical (NASDAQ:RMTI) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Rockwell Medical and Rockwell Medical both had 4 articles in the media. Rockwell Medical's average media sentiment score of 0.99 beat Accuray's score of 0.64 indicating that Rockwell Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Accuray
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 1.9% of Rockwell Medical shares are owned by company insiders. Comparatively, 4.2% of Accuray shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Accuray has a net margin of -0.35% compared to Rockwell Medical's net margin of -2.38%. Accuray's return on equity of -4.92% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-2.38% -6.79% -3.77%
Accuray -0.35%-4.92%-0.58%

Rockwell Medical has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Rockwell Medical presently has a consensus price target of $4.00, indicating a potential upside of 138.10%. Accuray has a consensus price target of $5.00, indicating a potential upside of 210.56%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Rockwell Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Accuray
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Rockwell Medical has higher earnings, but lower revenue than Accuray. Accuray is trading at a lower price-to-earnings ratio than Rockwell Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$101.49M0.57-$480K-$0.06-28.00
Accuray$458.51M0.40-$1.59M-$0.02-80.50

Summary

Rockwell Medical and Accuray tied by winning 8 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$57.84M$10.45B$5.69B$10.27B
Dividend YieldN/A1.86%5.72%4.60%
P/E Ratio-28.0021.3875.8626.51
Price / Sales0.5728.37489.92165.32
Price / Cash12.8125.0025.8129.89
Price / Book1.663.4312.846.32
Net Income-$480K$212.47M$3.28B$270.51M
7 Day Performance-6.67%-1.00%0.20%2.15%
1 Month Performance64.71%2.17%4.59%6.35%
1 Year Performance-56.36%-10.94%68.31%25.48%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
3.7833 of 5 stars
$1.68
+1.2%
$4.00
+138.1%
-57.2%$57.84M$101.49M-28.00300
ARAY
Accuray
4.7559 of 5 stars
$1.61
+2.5%
$5.00
+210.6%
-26.5%$176.90M$458.51M-80.501,040Analyst Upgrade
RSLS
ReShape Lifesciences
N/A$3.16
-1.4%
N/A-99.7%$8.49M$8.01M-0.0350Gap Down
High Trading Volume
ABT
Abbott Laboratories
4.9081 of 5 stars
$131.40
-1.7%
$144.47
+9.9%
+12.9%$232.75B$41.95B16.47114,000Positive News
ISRG
Intuitive Surgical
4.9481 of 5 stars
$433.99
-3.5%
$595.95
+37.3%
-11.4%$161.20B$8.35B60.5315,638Trending News
Analyst Revision
BSX
Boston Scientific
4.8365 of 5 stars
$99.75
-2.9%
$118.04
+18.3%
+19.7%$152.19B$16.75B59.3853,000Positive News
Options Volume
SYK
Stryker
4.9495 of 5 stars
$377.49
-1.5%
$431.42
+14.3%
+2.0%$146.55B$22.60B50.0053,000Positive News
MDT
Medtronic
4.9425 of 5 stars
$93.48
-0.6%
$102.14
+9.3%
+3.9%$120.61B$33.54B25.7595,000Positive News
BDX
Becton, Dickinson and Company
4.9516 of 5 stars
$185.90
-0.5%
$211.44
+13.7%
-20.6%$53.55B$20.18B33.4474,000News Coverage
Positive News
IDXX
IDEXX Laboratories
4.2395 of 5 stars
$643.99
+0.4%
$649.44
+0.8%
+28.7%$51.29B$3.90B53.6211,000Positive News
EW
Edwards Lifesciences
4.7489 of 5 stars
$76.10
-1.9%
$86.26
+13.4%
+11.1%$45.54B$5.44B10.9515,800News Coverage
Positive News
Analyst Downgrade
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners